PHARMAC funds tocilizumab to treat cases of COVID-19

16 September 2021 - PHARMAC is widening funded access to tocilizumab, an immunosuppressive drug used mainly to treat arthritis, to treat ...

Read more →

PHARMAC funds new treatment for rheumatoid arthritis to support people impacted by tocilizumab stock shortage

16 September 2021 - PHARMAC has funded upadacitinib tablets as an alternative treatment for New Zealanders with severe rheumatoid arthritis, ...

Read more →

Limiting the impact on Kiwis as API leaves the NZ market

14 September 2021 - PHARMAC is working hard to limit the impact on over 1 million Kiwis who currently take ...

Read more →

New Zealand’s tocilizumab supply to be paused

6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New ...

Read more →

New Zealand Pharmaceutical Schedule - 1 September 2021 update

1 September 2021 - The September 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding

26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...

Read more →

Dulaglutide receives Medsafe approval

23 August 2021 - Dulaglutide will be funded from 1 September 2021. ...

Read more →

Information Act shows racism in PHARMAC’s decision-making

17 August 2021 - Paati Māori Co-leader, Debbie Ngarewa-Packer, has received information that blatantly outlines the inequity within PHARMAC and ...

Read more →

PHARMAC to fund new cardiovascular medicine with amended Special Authority criteria

17 August 2021 - Pharmac has approved funding for a new medicine with substantial health benefits for around 75,000 New ...

Read more →

PHARMAC must explain funding decisions

16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...

Read more →

PHARMAC invites entire staff to top secret drug ranking meetings

16 August 2021 - Highly confidential meetings where PHARMAC ranks the funding priority of potentially life-saving medicines are open to ...

Read more →

Thousands of south Aucklanders could benefit from Medsafe approving new diabetes drug

12 August 2021 - Medsafe’s approval of a new drug for type 2 diabetes could dramatically change the lives of ...

Read more →

Treasury wanted Labour to break all health election promises bar one

5 August 2021 - Treasury told the Government to kick its election promises like funding for PHARMAC, cochlear implants, and ...

Read more →

Family says choice is life in Australia or death waiting for PHARMAC

2 August 2021 - A Tauranga couple is splitting up their family so their daughter can access treatment for spinal muscular ...

Read more →

New Zealand Pharmaceutical Schedule - 1 August 2021

1 August 2021 - The August 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →